Business Context and Reporting Period
This Form 8-K Current Report was filed by Colgate-Palmolive Company on December 8, 2016. The filing addresses corporate governance changes, specifically the election of a new director and the retirement of an existing director.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and director compensation arrangements.
Material Changes
- New Director Election: The Board elected Charles A. Bancroft, currently Executive Vice President and CFO of Bristol-Myers Squibb Company, to the Board of Directors effective January 1, 2017.
- Director Retirement: Richard J. Kogan advised the Board he will not stand for reelection at the 2017 Annual Meeting of Stockholders, intending to retire at the end of his current term.
Guidance, Outlook, and Compensation
Beginning in 2017, Mr. Bancroft will receive compensation under the standard non-employee director program, which includes:
- Annual cash retainer: $65,000
- Annual stock award: $180,000 value
- Annual stock option grant: $45,000 value
The filing contains no financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure of director appointments.
Investor Verification Checklist
- Verify the effective date of Charles A. Bancroft's board membership (January 1, 2017).
- Confirm the retirement timeline for Richard J. Kogan relative to the 2017 Annual Meeting.
- Review the March 23, 2016 proxy statement for full details on the director compensation program referenced in this filing.